Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases.
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
02 04 2020
02 04 2020
Historique:
received:
16
12
2019
revised:
17
02
2020
accepted:
05
03
2020
entrez:
4
4
2020
pubmed:
4
4
2020
medline:
21
10
2020
Statut:
ppublish
Résumé
Autoimmune diseases are a result of the immune system being misdirected toward its host and have major and increasing unmet clinical needs. In general, present therapies are broadly acting and non-disease specific; consequently, they are associated with numerous side effects. Precise and early intervention strategies are urgently needed. We highlight the challenges, progress, and prospects in achieving these goals.
Identifiants
pubmed: 32243797
pii: S0092-8674(20)30269-5
doi: 10.1016/j.cell.2020.03.007
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
63-80Subventions
Organisme : Medical Research Council
ID : MC_UU_00008/3
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100308/Z/12/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests J.R. has received funds to work on autoimmune diseases from Janssen Research & Development, LLC.